MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 575349 | Name: FCE-27164

Description:

WARNING: This product is for research use only, not for human or veterinary use.

FCE-27164 is a therapeutic agent that inhibits platelet-derived growth factor beta and IL-7 binding to their receptors.

Chemical Structure

FCE-27164
FCE-27164
CAS#154755-58-5

Theoretical Analysis

MedKoo Cat#: 575349

Name: FCE-27164

CAS#: 154755-58-5

Chemical Formula: C45H34N10Na6O23S6

Exact Mass: 1411.9509

Molecular Weight: 1413.11

Elemental Analysis: C, 38.25; H, 2.43; N, 9.91; Na, 9.76; O, 26.04; S, 13.61

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
FCE-27164; FCE27164; FCE 27164
IUPAC/Chemical Name
1,3,5-Naphthalenetrisulfonic acid, 7,7'-(carbonylbis(imino(1-methyl-1H-pyrrole-4,2-diyl)carbonylimino(1-methyl-1H-pyrrole-4,2-diyl)carbonylimino))bis-, hexasodium salt
InChi Key
NZHCYYWAUSIDGC-UHFFFAOYSA-H
InChi Code
InChI=1S/C45H40N10O23S6.6Na/c1-52-17-23(7-33(52)41(56)46-21-5-29-31(37(11-21)81(67,68)69)13-27(79(61,62)63)15-39(29)83(73,74)75)48-43(58)35-9-25(19-54(35)3)50-45(60)51-26-10-36(55(4)20-26)44(59)49-24-8-34(53(2)18-24)42(57)47-22-6-30-32(38(12-22)82(70,71)72)14-28(80(64,65)66)16-40(30)84(76,77)78;;;;;;/h5-20H,1-4H3,(H,46,56)(H,47,57)(H,48,58)(H,49,59)(H2,50,51,60)(H,61,62,63)(H,64,65,66)(H,67,68,69)(H,70,71,72)(H,73,74,75)(H,76,77,78);;;;;;/q;6*+1/p-6
SMILES Code
[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cn1cc(NC(=O)Nc2cc(C(=O)Nc3cc(C(=O)Nc4cc(c5cc(cc(c5c4)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])n(C)c3)n(C)c2)cc1C(=O)Nc6cc(C(=O)Nc7cc(c8cc(cc(c8c7)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])n(C)c6
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 1,413.11 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1. Ciomei M, Pastori W, Mariani M, Sola F, Grandi M, Mongelli N. New sulfonated distamycin A derivatives with bFGF complexing activity. Biochem Pharmacol. 1994 Jan 20;47(2):295-302. doi: 10.1016/0006-2952(94)90020-5. PMID: 7508230.